BioLineRx and I-Bridge Capital launch new joint venture

By Iris Dorbian — 4 days ago

Israeli biopharma company BioLineRX Ltd and I-Bridge Capital, a Chinese venture fund, have formed iPhama. The joint venture will focus on developing “innovative clinical and pre-clinical therapeutic candidates” mostly in Israel to serve the Chinese and global healthcare markets. According to the terms of the agreement, both BioLineRx and I-Bridge Capital will provide $1 million in seed funding to iPhama.